Sumit Aggarwal
Principal executive officer pay for Sumit Aggarwal, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Eloxx Pharmaceuticals, Inc. (ELOX) FY2023–FY2025
Aligned: paid up as stock roseCAP $977,771→$1,662,791 while $100 invested went $0.01→$13.19
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2023 | $1.3M | $977,771 |
| FY2024 | $991,692 | $991,698 |
| FY2025 | $1.8M | $1.7M |
The company's "$100 invested" index ran $0.01 at FY2023 → $13.19 by FY2025 — an annualized return of 3531.8%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 3531.8%/yr at ELOX ( FY2023–FY2025). See the CEO track-record ranking for context.